---  
layout: startup_page  
title: "Be Biopharma"  
id: "be.bio"  
permalink: "/bebiopharmabe.bio01152025/"  
website: "https://www.be.bio/"  
funding_round: "Series C"  
funding_amount: "$92M"  
investors: "Nextech, ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb, Takeda Ventures"  
about: "Be Biopharma pioneers Engineered B Cell Medicines (BCMs) to treat Hemophilia B and other genetic diseases. Their BCM platform creates durable, titratable, and redosable therapeutics without preconditioning, offering sustained therapeutic protein levels. This innovative approach aims to revolutionize treatment for various diseases."  
markets: "Biotechnology, Therapeutics, Cell Therapy, Pharmaceutical, Biopharma"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/be-biopharma-inc/"  
twitter: "https://twitter.com/bebiopharma"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/be-biopharma"  
pitchbook: ""  

date_display: "15-Jan-2025"  
date: "2025-01-15"

# SEO Optimization  
meta_title: "Be Biopharma - Series C Funding ($92M)"  
meta_description: "Be Biopharma, Be Biopharma pioneers Engineered B Cell Medicines (BCMs) to treat Hemophilia B and other genetic diseases. Their BCM platform creates durable, titrata..."  
meta_keywords: "Be Biopharma, Biotechnology, Therapeutics, Cell Therapy, Pharmaceutical, Biopharma, Series C funding"  
canonical_url: "https://startup.projectstartups.com/bebiopharmabe.bio01152025/"  
---